Inimmune
Missoula
About Inimmune
Inimmune is focused on the discovery and development of novel immunotherapeutics for an array of disease areas. Inimmune technology is focused on the discovery, optimization, and development of new innate immune receptor agonists and antagonists to treat a wide array of medical conditions including allergy, autoimmune diseases, and cancer. It was founded in 2016 and based in Missoula, Montana.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $22.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2020)
- Website: inimmune.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/inimmune-99564 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.